PostEra is building a modern 21st century biopharma. We're using our advances in machine learning to accelerate Medicinal Chemistry and bring more cures to patients. PostEra advances small molecule programs through partnerships with biopharma while also advancing its own internal pipeline. We've raised $26M from top investors and closed $1Bn in AI partnerships, signing multi-year agreements with Amgen, Pfizer and the NIH. PostEra also launched and led the world's largest open-science drug discovery effort; COVID Moonshot.
PostEra is revolutionizing the biopharma industry by leveraging advanced machine learning to streamline the Design-Make-Test cycle of medicinal chemistry, accelerating the discovery of new cures for patients.
PostEra offers customized pricing plans tailored to the specific needs of pharmaceutical companies and research institutions. Contact us for detailed pricing information and to discuss your project requirements.
PostEra's team comprises experts in machine learning, medicinal chemistry, and software development. Key team members include:
Our team is dedicated to pushing the boundaries of drug discovery and delivering innovative solutions to the biopharma industry.
Make undruggable targets a thing of the past
AI for Pharma Intelligence
AI platform accelerating therapies for rare & inflammatory diseases.
Perlara: building the YC for rare disease parents
Match with like-minded professionals for 1:1 conversations
Go from Slack Chaos to Clarity in Minutes
Personalize 1000s of landing pages in under 30 mins
The first LLM for document parsing with accuracy and speed
AI Assistants for SaaS professionals
AI-powered phone call app with live translation
Delightful AI-powered interactive demos—now loginless
AI Motion Graphics Copilot
Pop confetti to get rid of stress & anxiety, 100% AI-free
Smooth payments for SaaS